C116H83F24N33O11 — CID 173170211
3-[5-[5-ethoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]-2,6-difluorobenzamide;N-[5-[5-ethoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]-3,5-difluoropyridine-4-carboxamide;N-[5-[5-ethoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]-2-fluorobenzamide;N-[5-[5-ethoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]-3-fluoropyridine-4-carboxamide;N-[5-[5-ethoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]-3-methylpyridine-4-carboxamide;5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-amine (PubChem CID 173170211) has the molecular formula C116H83F24N33O11 and a molecular weight of 2571.11 g/mol. Its IUPAC name is 3-[5-[5-ethoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]-2,6-difluorobenzamide;N-[5-[5-ethoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]-3,5-difluoropyridine-4-carboxamide;N-[5-[5-ethoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]-2-fluorobenzamide;N-[5-[5-ethoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]-3-fluoropyridine-4-carboxamide;N-[5-[5-ethoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]-3-methylpyridine-4-carboxamide;5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-amine.
| Compound Name | 3-[5-[5-ethoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]-2,6-difluorobenzamide;N-[5-[5-ethoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]-3,5-difluoropyridine-4-carboxamide;N-[5-[5-ethoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]-2-fluorobenzamide;N-[5-[5-ethoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]-3-fluoropyridine-4-carboxamide;N-[5-[5-ethoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]-3-methylpyridine-4-carboxamide;5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-amine |
|---|---|
| PubChem CID | 173170211 |
| Molecular Formula | C116H83F24N33O11 |
| Molecular Weight | 2571.11 g/mol |
| Exact Mass | 2569.66 |
| IUPAC Name | 3-[5-[5-ethoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]-2,6-difluorobenzamide;N-[5-[5-ethoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]-3,5-difluoropyridine-4-carboxamide;N-[5-[5-ethoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]-2-fluorobenzamide;N-[5-[5-ethoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]-3-fluoropyridine-4-carboxamide;N-[5-[5-ethoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-yl]-3-methylpyridine-4-carboxamide;5-[5-methoxy-2-(trifluoromethyl)benzimidazol-1-yl]pyrazin-2-amine |
| SMILES | CCOc1ccc2c(c1)nc(C(F)(F)F)n2-c1cnc(-c2ccc(F)c(C(N)=O)c2F)cn1.CCOc1ccc2c(c1)nc(C(F)(F)F)n2-c1cnc(NC(=O)c2c(F)cncc2F)cn1.CCOc1ccc2c(c1)nc(C(F)(F)F)n2-c1cnc(NC(=O)c2ccccc2F)cn1.CCOc1ccc2c(c1)nc(C(F)(F)F)n2-c1cnc(NC(=O)c2ccncc2C)cn1.CCOc1ccc2c(c1)nc(C(F)(F)F)n2-c1cnc(NC(=O)c2ccncc2F)cn1.COc1ccc2c(c1)nc(C(F)(F)F)n2-c1cnc(N)cn1 |
| InChI | InChI=1S/C21H14F5N5O2.C21H15F4N5O2.C21H17F3N6O2.C20H13F5N6O2.C20H14F4N6O2.C13H10F3N5O/c1-2-33-10-3-6-15-13(7-10)30-20(21(24,25)26)31(15)16-9-28-14(8-29-16)11-4-5-12(22)17(18(11)23)19(27)32;1-2-32-12-7-8-16-15(9-12)28-20(21(23,24)25)30(16)18-11-26-17(10-27-18)29-19(31)13-5-3-4-6-14(13)22;1-3-32-13-4-5-16-15(8-13)28-20(21(22,23)24)30(16)18-11-26-17(10-27-18)29-19(31)14-6-7-25-9-12(14)2;1-2-33-10-3-4-14-13(5-10)29-19(20(23,24)25)31(14)16-9-27-15(8-28-16)30-18(32)17-11(21)6-26-7-12(17)22;1-2-32-11-3-4-15-14(7-11)28-19(20(22,23)24)30(15)17-10-26-16(9-27-17)29-18(31)12-5-6-25-8-13(12)21;1-22-7-2-3-9-8(4-7)20-12(13(14,15)16)21(9)11-6-18-10(17)5-19-11/h3-9H,2H2,1H3,(H2,27,32);3-11H,2H2,1H3,(H,26,29,31);4-11H,3H2,1-2H3,(H,26,29,31);3-9H,2H2,1H3,(H,27,30,32);3-10H,2H2,1H3,(H,26,29,31);2-6H,1H3,(H2,17,18) |
| InChIKey | XRXUTMGLOVYQCN-UHFFFAOYSA-N |
| XLogP | 23.69 |
| TPSA | 541.16 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 39 |
| Rotatable Bonds | 27 |
| Heavy Atoms | 184 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2571.11 |
| LogP ≤ 5 | 23.69 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 39 |